(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor
|
77108 |
|
15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitor
|
77108 |
|
15-hydroxyprostaglandin dehydrogenase (NAD(+)) (EC 1.1.1.141) inhibitors
|
77108 |
|
15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitor
|
77108 |
|
15-hydroxyprostaglandin dehydrogenase (NAD(+)) inhibitors
|
77108 |
|
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitors
|
77108 |
|
NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitor
|
77108 |
|
NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase (type I) inhibitors
|
77108 |
|
NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitor
|
77108 |
|
NAD-specific 15-hydroxyprostaglandin dehydrogenase inhibitors
|
77108 |
|
(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitor
|
77108 |
|